About Tethys BioScience
Tethys BioScience is a company based in Emeryville (United States) founded in 2002. It operates as a B2B. Tethys BioScience has raised $53.3 million across 5 funding rounds from investors including SVB, Kleiner Perkins and Oxford Finance. The company has 81 employees as of December 31, 2022. Tethys BioScience has completed 1 acquisition, including Lipomics. Tethys BioScience operates in a competitive market with competitors including Viome Life Sciences, Proteomics International, Mellitus, SmartZyme and Veralight, among others.
- Headquarter Emeryville, United States
- Employees 81 as on 31 Dec, 2022
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Tethys Bioscience, Inc
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of Tethys BioScience
Unlock access to complete
Leadership Team
2 people
Finance and Accounting
1 people
CLS Team
1 people
Medical Team
1 people
Unlock access to complete
Funding Insights of Tethys BioScience
Tethys BioScience has successfully raised a total of $53.3M across 5 strategic funding rounds. The most recent funding activity was a Series D round of $23 million completed in July 2010. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Tethys BioScience
Tethys BioScience has secured backing from 9 investors, including venture fund and institutional investors. Prominent investors backing the company include SVB, Kleiner Perkins and Oxford Finance.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture debt firm focused on the life sciences sector
|
Locked | Locked | Locked | |
|
Diversified investment management firm
|
Locked | Locked | Locked | |
|
Investment in technology startups focusing on compute, AI, and related innovations.
|
Locked | Locked | Locked |
Investor details for Tethys BioScience
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Tethys BioScience
Tethys BioScience has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Lipomics.
Investment portfolio details for Tethys BioScience
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Diagnostics for metabolic, cardiovascular, and inflammatory conditions are developed.
|
Locked | Locked | 2000 | Locked |
Complete acquisition details for Tethys BioScience
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Tethys BioScience
Detailed financials for Tethys BioScience
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Tethys Bioscience Comparisons
Peer comparison for Tethys BioScience
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Tethys BioScience
Tethys BioScience operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Viome Life Sciences, Proteomics International, Mellitus, SmartZyme and Veralight, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Provider of tests to prevent, treat, and cure chronic diseases, and cancer
|
|
| Locked | Locked | Locked |
Medical technology company at the forefront of predictive diagnostics and bio-analytical services
|
|
| Locked | Locked | Locked |
In vitro diagnostic test for Gestational Diabetes Mellitus (GDM)
|
|
| Locked | Locked | Locked |
Proprietary protein engineering technology is developed for diabetes products.
|
|
| Locked | Locked | Locked |
Offers biomarker screening solutions for early diabetes detection.
|
Detailed competitors of Tethys BioScience
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Tethys Bioscience
Complete news archive for Tethys BioScience
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Tethys BioScience
Tethys BioScience was founded in 2002 and raised its 1st funding round 3 years after it was founded.
Tethys BioScience is headquartered in Emeryville, United States. It is registered at Emeryville, California, United States.
Tethys BioScience is a funded company, having raised a total of $53.3M across 5 funding rounds to date.
As of Dec 31, 2022, the latest employee count at Tethys BioScience is 81.
Tethys BioScience develops biological markers for medical diagnostic applications through providing healthcare solutions, advancing biotech innovations, offering diagnostic solutions, and biomarkers. Prioritizing client-centric approaches, it ensures high-quality outcomes, innovation, and sustainable practices in its field. It continues to evolve, meeting industry challenges with strategic approaches.
Tethys BioScience's top competitors include Viome Life Sciences, Proteomics International and Mellitus.
Tethys BioScience has made 1 acquisition, including Lipomics.
Tethys BioScience has 9 investors. Key investors include SVB, Kleiner Perkins, Oxford Finance, Greenspring Associates, and Paul Capital.